BPC-157 vs GHK-Cu: Tissue Repair Peptides Compared

BPC-157 and GHK-Cu are both classified as healing/repair peptides, but they target fundamentally different tissue systems. BPC-157 (Body Protection Compound) is a 15-amino-acid gastric peptide that promotes angiogenesis and repairs internal tissues — tendons, ligaments, muscles, and gut lining. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide that remodels the extracellular matrix, stimulates collagen synthesis, and promotes skin and wound healing. Their complementary targets make them suitable for different research objectives in test subjects. For research purposes only.

BPC-157: Promotes angiogenesis (new blood vessel formation) at the site of injury, upregulates VEGF and FGF growth factors, modulates nitric oxide pathways, and accelerates tendon-to-bone healing. Works primarily through local injection near the target tissue. Most effective for deep structural tissue repair in test subjects. GHK-Cu: The copper ion activates over 4,000 genes involved in tissue remodelling. Stimulates collagen I, III, and V synthesis, increases decorin and glycosaminoglycan production, attracts immune cells to wound sites, and promotes new blood vessel growth in skin tissue. Works both locally (injection/topical) and systemically for extracellular matrix regeneration in test subjects.

BPC-157: • Dose: 200-600 mcg daily • Route: Subcutaneous injection near target area • Vial sizes: 5mg, 10mg • Reconstitution: 10mg + 2mL BAC water = 5mg/mL (50 mcg/unit) • 250 mcg = 5 units | 500 mcg = 10 units • Cycle: 4-6 weeks on, 2-4 weeks off GHK-Cu: • Dose: 1-2 mg daily (5 days/week) • Route: Subcutaneous injection • Vial sizes: 50mg, 100mg • Reconstitution: 50mg + 2mL BAC water = 25mg/mL (250 mcg/unit) • 1 mg = 4 units | 2 mg = 8 units • Cycle: 8-12 weeks on, 4 weeks off

Primary target: BPC-157 = Tendons, ligaments, gut, muscle | GHK-Cu = Skin, collagen, ECM Mechanism: BPC-157 = Angiogenesis + growth factors | GHK-Cu = Gene activation + copper signalling Best for tendons: BPC-157 = Excellent | GHK-Cu = Limited Best for skin/collagen: BPC-157 = Limited | GHK-Cu = Excellent Best for gut repair: BPC-157 = Excellent | GHK-Cu = Not researched Dose: BPC-157 = 200-600 mcg | GHK-Cu = 1-2 mg Cycle length: BPC-157 = 4-6 weeks | GHK-Cu = 8-12 weeks Injection site matters: BPC-157 = Yes (inject near target) | GHK-Cu = Less critical Topical option: BPC-157 = No | GHK-Cu = Yes (creams available) Cost per cycle: BPC-157 = Lower | GHK-Cu = Higher (larger doses)

Choose BPC-157 when: The research targets tendon, ligament, muscle, or gut tissue repair, localised injury healing is the objective, or the protocol requires a well-studied tissue repair peptide with extensive published literature in test subjects. Choose GHK-Cu when: The research focuses on skin regeneration, collagen synthesis, wound healing, or anti-aging effects on the extracellular matrix, or the protocol investigates copper-mediated gene activation in test subjects. For comprehensive healing research, some protocols combine both: BPC-157 for internal structural repair and GHK-Cu for skin/collagen support. For research purposes only.